Committee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA), Institute of Medicine (U.S.). Board on Health Sciences Policy, National Academies Press (U.S.), ebrary, Inc, Field, M. J., & Boat, T. F. (2012). Safe and effective medicines for children: Pediatric studies conducted under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. National Academies Press.
Chicago Style (17th ed.) CitationCommittee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA), Institute of Medicine (U.S.). Board on Health Sciences Policy, National Academies Press (U.S.), Inc ebrary, Marilyn J. Field, and Thomas F. Boat. Safe and Effective Medicines for Children: Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. Washington: National Academies Press, 2012.
MLA引文Committee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA), et al. Safe and Effective Medicines for Children: Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. National Academies Press, 2012.